The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach

Overview

Journal Pharmacoecon Open

Date 2020 Nov 9

PMID 33165825

Citations 4

Authors

Juan J DelaCruz

Mark Brennan-Ing

Andreas Kakolyris

Omar Martinez

Affiliations

Soon will be listed here.

Abstract

Background: There are noticeable gaps in knowledge regarding the cost and effectiveness of integrated medical and behavioral services for older adults with HIV. Their lifespan is close to the population's level but their quality of life has sharply declined due to depression and substance use. Mental health disorders are widespread among an aging population with HIV.

Objective: The aim of this study was to build a decision analytic model to evaluate medical interventions with and without mental health treatment using primary data of 139 older adults with HIV and health outcomes from the literature.

Methods: We tracked the progression of depression and cumulative deaths among older adults with HIV using a Markov model with 50 annual cycles through three health states. Deterministic and probabilistic sensitivity analyses addressed uncertainty in estimating the parameters and around the model's assumptions.

Results: An integrated medical and behavioral care system is cost effective at a willingness to pay of $50,000 per QALY compared with medical care only. The incremental cost was $516,452 and the incremental effectiveness was 38.8 quality-adjusted life-years (QALY), with an incremental cost-effectiveness ratio of $13,316 per QALY.

Conclusions: Appropriate and efficacious referrals to integrated medical + behavioral services, either in the same facility or connected to their primary care doctor, are instrumental to reverse loses in quality of life and avoid premature death. If mental health is left unattended, HIV would progress, causing declines in quality of life and ultimately triggering premature death. Reliable data on the cost and effectiveness of different types of HIV integrated services are needed.

Citing Articles

COVID-19, Race/Ethnicity, and Age: the Role of Telemedicine to Close the Gaps on Health Disparities.

Kakolyris A, DelaCruz J, Giannikos C J Econ Race Policy. 2022; 5(4):241-251.

PMID: 35300311 PMC: 8390063. DOI: 10.1007/s41996-021-00089-y.

Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan.

Yamamoto N, Koizumi Y, Tsuzuki S, Ejima K, Takano M, Iwami S Sci Rep. 2022; 12(1):3088.

PMID: 35197543 PMC: 8866502. DOI: 10.1038/s41598-022-07116-4.

Cost-Effectiveness Analysis Combining Medical and Mental Health Services for Older Adults with HIV in New York City.

DelaCruz J, Giannikos C, Kakolyris A, Utzinger R, Karpiak S Atl Econ J. 2021; 49(1):43-56.

PMID: 34040269 PMC: 8143031. DOI: 10.1007/s11293-021-09697-3.

Modelling the Economic Impact of Reducing Loneliness in Community Dwelling Older People in England.

McDaid D, Park A Int J Environ Res Public Health. 2021; 18(4).

PMID: 33546496 PMC: 7913744. DOI: 10.3390/ijerph18041426.

References

Nakimuli-Mpungu E, Musisi S, Wamala K, Okello J, Ndyanabangi S, Birungi J . Effectiveness and cost-effectiveness of group support psychotherapy delivered by trained lay health workers for depression treatment among people with HIV in Uganda: a cluster-randomised trial. Lancet Glob Health. 2020; 8(3):e387-e398. DOI: 10.1016/S2214-109X(19)30548-0. View

Hutton H, Lyketsos C, Zenilman J, Thompson R, Erbelding E . Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry. 2004; 161(5):912-4. DOI: 10.1176/appi.ajp.161.5.912. View

McCabe C, Brazier J, Gilks P, Tsuchiya A, Roberts J, OHagan A . Using rank data to estimate health state utility models. J Health Econ. 2006; 25(3):418-31. DOI: 10.1016/j.jhealeco.2005.07.008. View

Ogburn D, Schoenbach V, Edmonds A, Pence B, Powers K, White B . Depression, ART Adherence, and Receipt of Case Management Services by Adults with HIV in North Carolina, Medical Monitoring Project, 2009-2013. AIDS Behav. 2018; 23(4):1004-1015. DOI: 10.1007/s10461-018-2365-1. View

Clifford D, Ances B . HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013; 13(11):976-86. PMC: 4108270. DOI: 10.1016/S1473-3099(13)70269-X. View

van den Berg M, Smit F, Vos T, van Baal P . Cost-effectiveness of opportunistic screening and minimal contact psychotherapy to prevent depression in primary care patients. PLoS One. 2011; 6(8):e22884. PMC: 3154255. DOI: 10.1371/journal.pone.0022884. View

Korthuis P, McGinnis K, Kraemer K, Gordon A, Skanderson M, Justice A . Quality of HIV Care and Mortality Rates in HIV-Infected Patients. Clin Infect Dis. 2015; 62(2):233-239. PMC: 4690479. DOI: 10.1093/cid/civ762. View

Brazier J, Roberts J, Deverill M . The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002; 21(2):271-92. DOI: 10.1016/s0167-6296(01)00130-8. View

Sales J, Swartzendruber A, Phillips A . Trauma-Informed HIV Prevention and Treatment. Curr HIV/AIDS Rep. 2016; 13(6):374-382. PMC: 5107145. DOI: 10.1007/s11904-016-0337-5. View

10.

Xiao Y, Sun X, Tang S, Zhou Y, Peng Z, Wu J . Personalized life expectancy and treatment benefit index of antiretroviral therapy. Theor Biol Med Model. 2017; 14(1):1. PMC: 5242026. DOI: 10.1186/s12976-016-0047-0. View

11.

Brennan-Ing M, Seidel L, Karpiak S . Social Support Systems and Social Network Characteristics of Older Adults with HIV. Interdiscip Top Gerontol Geriatr. 2016; 42:159-172. DOI: 10.1159/000448561. View

12.

Garrison Jr L, Pauly M, Willke R, Neumann P . An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]. Value Health. 2018; 21(2):124-130. DOI: 10.1016/j.jval.2017.12.006. View

13.

Arias E . United States Life Tables, 2017. Natl Vital Stat Rep. 2020; 68(7):1-66. View

14.

Nizami S, Morales C, Hu K, Holzman R, Rapkiewicz A . Trends in Mortality From Human Immunodeficiency Virus Infection, 1984-2016: An Autopsy-Based Study. Arch Pathol Lab Med. 2019; 144(5):572-579. DOI: 10.5858/arpa.2019-0144-OA. View

15.

Flash M, Garland W, Martey E, Schackman B, Oksuzyan S, Scott J . Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles County. Open Forum Infect Dis. 2020; 6(12):ofz537. PMC: 6935680. DOI: 10.1093/ofid/ofz537. View

16.

Lucas S, Nelson A . HIV and the spectrum of human disease. J Pathol. 2014; 235(2):229-41. DOI: 10.1002/path.4449. View

17.

Verheul H, Dekker E, Bossuyt P, Moulijn A, Dunning A . Background mortality in clinical survival studies. Lancet. 1993; 341(8849):872-5. DOI: 10.1016/0140-6736(93)93073-a. View

18.

Milanini B, Valcour V . Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV. Curr HIV/AIDS Rep. 2017; 14(4):123-132. PMC: 5823609. DOI: 10.1007/s11904-017-0361-0. View

19.

Kall A, Jagholm S, Hesser H, Andersson F, Mathaldi A, Norkvist B . Internet-Based Cognitive Behavior Therapy for Loneliness: A Pilot Randomized Controlled Trial. Behav Ther. 2020; 51(1):54-68. DOI: 10.1016/j.beth.2019.05.001. View

20.

Grov C, Golub S, Parsons J, Brennan M, Karpiak S . Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care. 2010; 22(5):630-9. PMC: 2936670. DOI: 10.1080/09540120903280901. View